Is BTTX or UPHL more profitable?

Company Net Margins Return on Equity Return on Assets Better Therapeutics N/A N/A N/A UpHealth N/A N/A N/A

Is BACK or BTTX more profitable?

Company Net Margins Return on Equity Return on Assets IMAC N/A N/A -325.44% Better Therapeutics N/A N/A N/A

Which has stronger valuation and earnings, BTTX or ACONW?

Aclarion has higher revenue and earnings than Better Therapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Better Therapeutics N/A N/A -$39.76M -$0.39 N/A Aclarion $77.88K N/A N/A N/A N/A

Is BTTX or ACONW more profitable?

Company Net Margins Return on Equity Return on Assets Better Therapeutics N/A N/A N/A Aclarion N/A N/A N/A

Which has preferable valuation & earnings, BTTX or DHACW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Better Therapeutics N/A N/A -$39.76M -$0.39 N/A Digital Health Acquisition N/A N/A N/A N/A N/A

Is BTTX or DHACW more profitable?

Company Net Margins Return on Equity Return on Assets Better Therapeutics N/A N/A N/A Digital Health Acquisition N/A N/A N/A

Which has better earnings and valuation, LFMDP or BTTX?

LifeMD has higher revenue and earnings than Better Therapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LifeMD $193.33M N/A N/A N/A N/A Better Therapeutics N/A N/A -$39.76M -$0.39 N/A

Is LFMDP or BTTX more profitable?

Company Net Margins Return on Equity Return on Assets LifeMD N/A N/A N/A Better Therapeutics N/A N/A N/A

Better Therapeutics (BTTX) Competitors

$0.0001 0.00 (0.00%)

As of 07/29/2026 10:13 AM Eastern

Compare

BTTX vs. UPHL, BACK, ACONW, DHACW, and LFMDP

Should you buy Better Therapeutics stock or one of its competitors? MarketBeat compares Better Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Better Therapeutics include UpHealth (UPHL), IMAC (BACK), Aclarion (ACONW), Digital Health Acquisition (DHACW), and LifeMD (LFMDP). These companies are all part of the "healthcare" industry.

How does Better Therapeutics compare to UpHealth?

Better Therapeutics (NASDAQ:BTTX) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, valuation, dividends, risk and institutional ownership.

Better Therapeutics has higher earnings, but lower revenue than UpHealth. Better Therapeutics is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Better Therapeutics	N/A	N/A	-$39.76M	-$0.39	N/A
UpHealth	$130M	0.00	-$56.42M	$1.98	0.00

Company	Net Margins	Return on Equity	Return on Assets
Better Therapeutics	N/A	N/A	N/A
UpHealth	N/A	N/A	N/A

Better Therapeutics has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market. Comparatively, UpHealth has a beta of 0.5, indicating that its share price is 50% less volatile than the broader market.

34.0% of Better Therapeutics shares are owned by institutional investors. Comparatively, 56.1% of UpHealth shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by insiders. Comparatively, 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company	Overall Sentiment
Better Therapeutics	Neutral
UpHealth	Neutral

Summary

UpHealth beats Better Therapeutics on 4 of the 7 factors compared between the two stocks.

How does Better Therapeutics compare to IMAC?

IMAC (NASDAQ:BACK) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

IMAC has higher revenue and earnings than Better Therapeutics. Better Therapeutics is trading at a lower price-to-earnings ratio than IMAC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IMAC	$72.05K	0.01	-$9.42M	-$3.12	N/A
Better Therapeutics	N/A	N/A	-$39.76M	-$0.39	N/A

IMAC has a beta of 1.68, meaning that its stock price is 68% more volatile than the broader market. Comparatively, Better Therapeutics has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
IMAC	N/A	N/A	-325.44%
Better Therapeutics	N/A	N/A	N/A

5.8% of IMAC shares are owned by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are owned by institutional investors. 12.3% of IMAC shares are owned by company insiders. Comparatively, 51.4% of Better Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, IMAC's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score.

Company	Overall Sentiment
IMAC	Neutral
Better Therapeutics	Neutral

Summary

IMAC and Better Therapeutics tied by winning 4 of the 8 factors compared between the two stocks.

How does Better Therapeutics compare to Aclarion?

Better Therapeutics (NASDAQ:BTTX) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

Aclarion has higher revenue and earnings than Better Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Better Therapeutics	N/A	N/A	-$39.76M	-$0.39	N/A
Aclarion	$77.88K	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Better Therapeutics	N/A	N/A	N/A
Aclarion	N/A	N/A	N/A

34.0% of Better Therapeutics shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Aclarion had 2 more articles in the media than Better Therapeutics. MarketBeat recorded 2 mentions for Aclarion and 0 mentions for Better Therapeutics. Aclarion's average media sentiment score of 1.44 beat Better Therapeutics' score of 0.00 indicating that Aclarion is being referred to more favorably in the news media.

Company	Overall Sentiment
Better Therapeutics	Neutral
Aclarion	Positive

Summary

Aclarion beats Better Therapeutics on 3 of the 5 factors compared between the two stocks.

How does Better Therapeutics compare to Digital Health Acquisition?

Better Therapeutics (NASDAQ:BTTX) and Digital Health Acquisition (NASDAQ:DHACW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company	Overall Sentiment
Better Therapeutics	Neutral
Digital Health Acquisition	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Better Therapeutics	N/A	N/A	-$39.76M	-$0.39	N/A
Digital Health Acquisition	N/A	N/A	N/A	N/A	N/A

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
Better Therapeutics	N/A	N/A	N/A
Digital Health Acquisition	N/A	N/A	N/A

Summary

Better Therapeutics beats Digital Health Acquisition on 2 of the 2 factors compared between the two stocks.

How does Better Therapeutics compare to LifeMD?

LifeMD (NASDAQ:LFMDP) and Better Therapeutics (NASDAQ:BTTX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, LifeMD had 2 more articles in the media than Better Therapeutics. MarketBeat recorded 2 mentions for LifeMD and 0 mentions for Better Therapeutics. LifeMD's average media sentiment score of 1.43 beat Better Therapeutics' score of 0.00 indicating that LifeMD is being referred to more favorably in the media.

Company	Overall Sentiment
LifeMD	Positive
Better Therapeutics	Neutral

LifeMD has higher revenue and earnings than Better Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$193.33M	N/A	N/A	N/A	N/A
Better Therapeutics	N/A	N/A	-$39.76M	-$0.39	N/A

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	N/A	N/A	N/A
Better Therapeutics	N/A	N/A	N/A

Summary

LifeMD beats Better Therapeutics on 3 of the 5 factors compared between the two stocks.

Get Better Therapeutics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BTTX vs. The Competition

Export

Metric	Better Therapeutics	Health services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4K	$923.67K	$7.04B	$12.05B
Dividend Yield	N/A	N/A	2.65%	10.11%
P/E Ratio	0.00	N/A	27.69	23.57
Price / Sales	N/A	0.00	485.60	77.17
Price / Cash	N/A	N/A	51.74	58.30
Price / Book	N/A	0.00	10.16	5.85
Net Income	-$39.76M	-$48.09M	$3.60B	$336.53M
7 Day Performance	N/A	N/A	0.66%	0.35%
1 Month Performance	N/A	N/A	-3.29%	-4.99%
1 Year Performance	N/A	N/A	24.49%	17.95%

Better Therapeutics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BTTX Better Therapeutics	N/A	$0.00 flat	N/A	+0.0%	$4K	N/A	N/A	40
UPHL UpHealth	N/A	$0.00 flat	N/A	+50.0%	$6K	$130M	N/A	1,750
BACK IMAC	N/A	$0.00 flat	N/A	-99.7%	$1K	$72.05K	N/A	180
ACONW Aclarion	N/A	$0.02 +6.7%	N/A	-16.2%	$0.00	$77.88K	N/A	7	Short Interest Decrease
DHACW Digital Health Acquisition	N/A	$0.02 -2.4%	N/A	-55.6%	$0.00	N/A	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BTTX) was last updated on 7/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Better Therapeutics (BTTX) Competitors

BTTX vs. UPHL, BACK, ACONW, DHACW, and LFMDP

How does Better Therapeutics compare to UpHealth?

Summary

How does Better Therapeutics compare to IMAC?

Summary

How does Better Therapeutics compare to Aclarion?

Summary

How does Better Therapeutics compare to Digital Health Acquisition?

Summary

How does Better Therapeutics compare to LifeMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BTTX vs. The Competition

Better Therapeutics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Better Therapeutics (BTTX) Competitors

BTTX vs. UPHL, BACK, ACONW, DHACW, and LFMDP

How does Better Therapeutics compare to UpHealth?

Which has stronger valuation & earnings, BTTX or UPHL?

Is BTTX or UPHL more profitable?

Which has more risk and volatility, BTTX or UPHL?

Do institutionals & insiders have more ownership in BTTX or UPHL?

Does the media prefer BTTX or UPHL?

Summary

How does Better Therapeutics compare to IMAC?

Which has higher earnings and valuation, BACK or BTTX?

Which has more risk & volatility, BACK or BTTX?

Is BACK or BTTX more profitable?

Do institutionals & insiders hold more shares of BACK or BTTX?

Does the media refer more to BACK or BTTX?

Summary

How does Better Therapeutics compare to Aclarion?

Which has stronger valuation and earnings, BTTX or ACONW?

Is BTTX or ACONW more profitable?

Do institutionals & insiders hold more shares of BTTX or ACONW?

Does the media refer more to BTTX or ACONW?

Summary

How does Better Therapeutics compare to Digital Health Acquisition?

Does the media prefer BTTX or DHACW?

Which has preferable valuation & earnings, BTTX or DHACW?

Do insiders & institutionals have more ownership in BTTX or DHACW?

Is BTTX or DHACW more profitable?

Summary

How does Better Therapeutics compare to LifeMD?

Do insiders & institutionals have more ownership in LFMDP or BTTX?

Does the media favor LFMDP or BTTX?

Which has better earnings and valuation, LFMDP or BTTX?

Is LFMDP or BTTX more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BTTX vs. The Competition

Better Therapeutics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools